Return On Assets of CRESCENT BIOPHARMA, INC. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CRESCENT BIOPHARMA, INC. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • CRESCENT BIOPHARMA, INC. Return On Assets for the quarter ending 30 Sep 2025 was -90%, a 171% decline year-over-year.
  • CRESCENT BIOPHARMA, INC. annual Return On Assets for 2024 was -138%, a 114% decline from 2023.
  • CRESCENT BIOPHARMA, INC. annual Return On Assets for 2023 was -64%, a 12% increase from 2022.
  • CRESCENT BIOPHARMA, INC. annual Return On Assets for 2022 was -73%, a 35% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

CRESCENT BIOPHARMA, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -90% -57% -171% 01 Jul 2025 30 Sep 2025
Q2 2025 -101% -1% -1% 01 Apr 2025 30 Jun 2025
Q1 2025 -207% -130% -170% 01 Jan 2025 31 Mar 2025
Q4 2024 -138% -73% -114% 01 Oct 2024 31 Dec 2024
Q3 2024 -33% +31% +49% 20 Sep 2024 30 Sep 2024
Q2 2024 -100% -37% -59% 01 Apr 2024 30 Jun 2024
Q1 2024 -77% -6% -9.3% 01 Jan 2024 31 Mar 2024
Q4 2023 -64% +9% +12% 01 Oct 2023 31 Dec 2023
Q3 2023 -65% +8% +11% 01 Jul 2023 30 Sep 2023
Q2 2023 -63% +9% +13% 01 Apr 2023 30 Jun 2023
Q1 2023 -70% -8% -12% 01 Jan 2023 31 Mar 2023
Q4 2022 -73% -19% -35% 01 Oct 2022 31 Dec 2022
Q3 2022 -73% -25% -51% 01 Jul 2022 30 Sep 2022
Q2 2022 -72% -30% -72% 01 Apr 2022 30 Jun 2022
Q1 2022 -63% -23% -60% 01 Jan 2022 31 Mar 2022
Q4 2021 -55% -21% -64% 01 Oct 2021 31 Dec 2021
Q3 2021 -48% -17% -53% 01 Jul 2021 30 Sep 2021
Q2 2021 -42% -12% -40% 01 Apr 2021 30 Jun 2021
Q1 2021 -39% -10% -33% 01 Jan 2021 31 Mar 2021
Q4 2020 -33% -2% -7% 01 Oct 2020 31 Dec 2020
Q3 2020 -31% -3% -9% 01 Jul 2020 30 Sep 2020
Q2 2020 -30% -3% -12% 01 Apr 2020 30 Jun 2020
Q1 2020 -29% -6% -27% 01 Jan 2020 31 Mar 2020
Q4 2019 -31% -10% -49% 01 Oct 2019 31 Dec 2019
Q3 2019 -29% -8% -38% 01 Jul 2019 30 Sep 2019
Q2 2019 -26% -4% -20% 01 Apr 2019 30 Jun 2019
Q1 2019 -23% +1% +3.9% 01 Jan 2019 31 Mar 2019
Q4 2018 -21% +12% +37% 01 Oct 2018 31 Dec 2018
Q3 2018 -21% +20% +49% 01 Jul 2018 30 Sep 2018
Q2 2018 -22% +30% +58% 01 Apr 2018 30 Jun 2018
Q1 2018 -24% +46% +66% 01 Jan 2018 31 Mar 2018
Q4 2017 -33% +35% +52% 01 Oct 2017 31 Dec 2017
Q3 2017 -41% +26% +39% 01 Jul 2017 30 Sep 2017
Q2 2017 -52% +11% +18% 01 Apr 2017 30 Jun 2017
Q1 2017 -70% -45% -175% 01 Jan 2017 31 Mar 2017
Q4 2016 -68% -44% -186% 01 Oct 2016 31 Dec 2016
Q3 2016 -67% -47% -232% 01 Jul 2016 30 Sep 2016
Q2 2016 -63% -44% -239% 01 Apr 2016 30 Jun 2016
Q1 2016 -26% -3% -15% 01 Jan 2016 31 Mar 2016
Q4 2015 -24% -6% -31% 01 Oct 2015 31 Dec 2015
Q3 2015 -20% -4% -28% 01 Jul 2015 30 Sep 2015
Q2 2015 -19% 01 Apr 2015 30 Jun 2015
Q1 2015 -22% 01 Jan 2015 31 Mar 2015
Q4 2014 -18% 01 Oct 2014 31 Dec 2014
Q3 2014 -16% 01 Jul 2014 30 Sep 2014

CRESCENT BIOPHARMA, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -138% -73% -114% 01 Jan 2024 31 Dec 2024
2023 -64% +9% +12% 01 Jan 2023 31 Dec 2023
2022 -73% -19% -35% 01 Jan 2022 31 Dec 2022
2021 -55% -21% -64% 01 Jan 2021 31 Dec 2021
2020 -33% -2% -7% 01 Jan 2020 31 Dec 2020
2019 -31% -10% -49% 01 Jan 2019 31 Dec 2019
2018 -21% +12% +37% 01 Jan 2018 31 Dec 2018
2017 -33% +35% +52% 01 Jan 2017 31 Dec 2017
2016 -68% -44% -186% 01 Jan 2016 31 Dec 2016
2015 -24% -6% -31% 01 Jan 2015 31 Dec 2015
2014 -18% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.